Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the preparation of β-substituted γ-amino acids and other bioactive molecules. Its trifluoromethanesulfonyloxy (triflate) group acts as a leaving group, enabling palladium-catalyzed cross-coupling reactions. The compound is valuable in asymmetric synthesis due to its enantiomerically pure form, allowing for the construction of complex molecular architectures in drug development, especially in CNS agents and protease inhibitors.